FLEX Arteriovenous Access Registry

NCT04070365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2022-05-31

No results posted yet for this study

Summary

Evaluation of the FLEX Vessel Prep system combined with angioplasty in the treatment of arteriovenous access stenosis.

Conditions

Interventions

DEVICE

FLEX Vessel Prep System followed by angioplasty

Eligible Arteriovenous Fistula (AVF)/Arteriovenous Graft (AVG) will be treated with the FLEX Vessel Prep system followed by angioplasty.

Sponsors & Collaborators

  • VentureMed Group Inc.

    lead INDUSTRY

Principal Investigators

  • John Aruny, MD · Dialysis Access Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-28
Primary Completion
2021-06-09
Completion
2022-05-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04070365 on ClinicalTrials.gov